Abstract:PURPOSE: Split thickness skin graft (STSG) implantation is one of the standard therapies for full thickness wound repair when autologous skin full thickness graft (FTG) or skin flap transplants are inapplicable. However, STSG are more fragile than FTG and can contract significantly during the healing process. Human mesenchymal stem cells (hMSCs) are capable of accelerating the wound healing process. So we use pre-vascularized hMSC sheets (PHCS) to study if they would further improve the repair quality of STSG. METHODS:In vitro cultured control hMSC cell sheets (HCS) were obtained after four weeks culture in complete culture medium (CCM), then endothelial cells (ECs) were cocultured on top of the hMSC sheets for 1 week to get PHCS. Immunofluorescence staining was used to characterize both cell sheets. The progenitor population and multi-lineage differentiation ability of hMSCs inside the cell sheets were tested. The angiogenic growth factor amount present in the cell sheets was also analyzed using an enzyme-linked immunosorbent assay (ELISA). The cell sheets were applied in combination with an autologous STSG in rats with full thickness skin wound. Graft survival and contraction was evaluated and the implants were harvested at predetermined time points for analysis (n=6 animals per group). Histology and immunohistochemistry were performed to test if PHCS can enhance the therapeutic effects of STSG. RESULTS: The hMSCs in HCS still maintain self-renewal and differentiation capacity after extended periods of culture. The TGF-β1, ANG1 and ANG2 amount in PHCS was higher than HCS (p<0.05) whereas the VEGF amount in PHCS was significantly lower than that in HCS (p<0.05). The HCS and the PHCS implantation significantly reduced skin contraction and improved cosmetic appearance relative to the STSG control group. The PHCS group experienced the least hemorrhage and necrosis, and lowest inflammatory cell infiltration. It also induced the highest neovascularization in early stages, which established a robust blood micro-circulation to support grafts survival and tissue regeneration. Moreover, the PHCS grafts preserved the largest amount of skin appendages (including hair follicles and sebaceous glands) and developed the smallest epidermal thickness. The collagen deposition and fibril morphology in PHCS grafts were also similar to normal skin, indicating a lower degree of skin fibrosis. The superior therapeutic effect seen in PHCS groups was attributed to the elevated presence of growth factors and cytokines in the pre-vascularized cell sheet, which exerted a beneficial paracrine signaling during the early stage of wound repair. CONCLUSION: The strategy of combining autologous STSG with PHCS implantation appears to be a promising approach in regenerative treatment of full thickness skin wounds.

Pre-vascularization Enhances Therapeutic Effects of Human Mesenchymal Stem Cell Sheets in Full Thickness Skin Wound Repair

Abstract P21: Enhancement of Therapeutic Benefits of Split Thickness Skin Grafts Using Pre-vascularized Human Mesenchymal Stem Cells

Protocols for Full Thickness Skin Wound Repair Using Prevascularized Human Mesenchymal Stem Cell Sheet.

Prevascularized Mesenchymal Stem Cell-Sheets Increase Survival of Random Skin Flaps in a Nude Mouse Model

Conditioned Medium from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Accelerates Cutaneous Wound Healing Through Enhanced Angiogenesis.

Combination therapy of placenta-derived mesenchymal stem cells and artificial dermal scaffold promotes full-thickness skin defects vascularization in rat animal model

Bio-inspired Microvascular Patches with MSC Encapsulation for Wound Healing

In Situ-Formed Fibrin Hydrogel Scaffold Loaded With Human Umbilical Cord Mesenchymal Stem Cells Promotes Skin Wound Healing

Fabricating Composite Cell Sheets for Wound Healing: Cell Sheets Based on the Communication Between BMSCs and HFSCs Facilitate Full-Thickness Cutaneous Wound Healing

Single-stage transplantation combined with epidermal stem cells promotes the survival of tissue-engineered skin by inducing early angiogenesis

Human mesenchymal stem cells successfully improve skin-substitute wound healing

Transplantation of bone-marrow-derived mesenchymal and epidermal stem cells contribute to wound healing with different regenerative features

Human Placenta-Derived Mesenchymal Stem Cells Combined With Artificial Dermal Scaffold Enhance Wound Healing in a Tendon-Exposed Wound of a Rabbit Model

Mesenchymal Stem Cells Pretreated with Collagen Promote Skin Wound-Healing

Second-harmonic generation microscopy for assessment of mesenchymal stem cell-seeded acellular dermal matrix in wound-healing.

A study of enhancing effect of mesenchymal stem cells in healing of experimental epidermal "wound" in vitro

Repair and regeneration of skin injury by transplanting microparticles mixed with Wharton's jelly and MSCs from the human umbilical cord

Thermosensitive hydrogel coupled with sodium ascorbyl phosphate promotes human umbilical cord-derived mesenchymal stem cell-mediated skin wound healing in mice

Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury.

Hypoxia Pretreatment of Bone Marrow-Derived Mesenchymal Stem Cells Seeded in a Collagen-Chitosan Sponge Scaffold Promotes Skin Wound Healing in Diabetic Rats with Hindlimb Ischemia.

Advances in Mesenchymal Stem Cell Therapy for Cutaneous Wounds